ID: ALA3137656

Max Phase: Preclinical

Molecular Formula: C20H16F3N5O

Molecular Weight: 399.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Fc1ccc(CCNc2cn3c(-c4ccc(OC(F)F)cc4)nnc3cn2)cc1

Standard InChI:  InChI=1S/C20H16F3N5O/c21-15-5-1-13(2-6-15)9-10-24-17-12-28-18(11-25-17)26-27-19(28)14-3-7-16(8-4-14)29-20(22)23/h1-8,11-12,20,24H,9-10H2

Standard InChI Key:  GVXYAEXVJYZTBB-UHFFFAOYSA-N

Associated Targets(non-human)

Plasmodium falciparum 966862 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 399.38Molecular Weight (Monoisotopic): 399.1307AlogP: 4.19#Rotatable Bonds: 7
Polar Surface Area: 64.34Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 1.76CX LogP: 3.60CX LogD: 3.60
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.51Np Likeness Score: -1.80

References

1. Open Source Malaria Deposition 2. http://malaria.ourexperiment.org,  [10.6019/CHEMBL3137547]
2. Tse EG, Aithani L, Anderson M, Cardoso-Silva J, Cincilla G, Conduit GJ, Galushka M, Guan D, Hallyburton I, Irwin BWJ, Kirk K, Lehane AM, Lindblom JCR, Lui R, Matthews S, McCulloch J, Motion A, Ng HL, Öeren M, Robertson MN, Spadavecchio V, Tatsis VA, van Hoorn WP, Wade AD, Whitehead TM, Willis P, Todd MH..  (2021)  An Open Drug Discovery Competition: Experimental Validation of Predictive Models in a Series of Novel Antimalarials.,  64  (22.0): [PMID:34748707] [10.1021/acs.jmedchem.1c00313]